New therapy uses electricity to cancel out Parkinson tremors

February 18, 2013 in Parkinson's & Movement disorders

New therapy uses electricity to cancel out Parkinson tremors

A new therapy for Parkinson's cancels out brain signals causing the characteristic tremors.

A new therapy could help suppress tremors in people with Parkinson's disease, an Oxford University study suggests.

The technique – called transcranial alternating current stimulation or TACS – cancels out the causing the tremors by applying a small, safe electric current across electrodes on the outside of a patient's head.

The preliminary study, conducted with 15 people with Parkinson's disease at Oxford's John Radcliffe Hospital, is published in the journal . The researchers showed a 50 per cent reduction in resting tremors among the patients.

Physical tremors are a significant and debilitating symptom of Parkinson's disease, but do not respond well to existing drug treatments.

Tremors can be successfully treated with deep stimulation, a technique that involves surgery to insert electrodes deep into the brain itself to deliver . But this is expensive and carries some health risks, including bleeding in to the brain, which means it is not suitable for all patients.

In TACS in contrast, the electrode pads are placed on the outside of the patient's head, so it does not carry the risks associated with .

Professor Peter Brown of the Nuffield Department of Clinical Neurosciences, who led the study, said: 'Tremors experienced by Parkinson's sufferers can be devastating and any therapy that can suppress or reduce those tremors significantly improves quality of life for patients.

'We are very hopeful this research may, in time, lead to a therapy that is both successful and carries reduced medical risks. We have proved the principle, now we have to optimise it and adapt it so it is able to be used in patients. Often that is the hardest part.'

The research was supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (Oxford BRC), a collaboration between Oxford University Hospitals NHS Trust and Oxford University to accelerate healthcare innovation. It was also supported by the Medical Research Council, Rosetrees Trust, the Wellcome Trust and the Engineering and Physical Sciences Research Council.

TACS works by placing two electrode pads on the patient, one close to the base of the neck and one on the head, above the motor cortex (part of the brain implicated in controlling the tremors).

The small alternating current stimulation the electrodes deliver is matched to the oscillating tremor signal to cancel it out, and suppress the physical tremor.

Professor Brown said: 'The approach is based on the fact the brain operates using brain waves. If we can stimulate with matching waves we can either replace a signal that is absent or, in this case, cancel out a pathological brain wave.

'It is similar to the principle of noise-cancelling headphones that we are all familiar with. Those headphones detect ambient noise and then produce a signal to cancel it out.'

Professor Brown said the therapy now had to be developed into a viable patient treatment for Parkinson's tremors, which could involve a system that would continually detect the brain signal and adjust the delivered stimulation to cancel it out.

He said such technology could involve a system where pads were placed under the skin, allowing the therapy to remain 'minimally invasive' to reduce risk but making it more convenient for a patient to be fitted with the device.

He added: 'There would be nothing to see, no wires on show, but it would deliver stimulation continuously.'

Professor Brown said further work would also look at the effectiveness of prolonged stimulation and whether the therapy may help the brain adapt itself to control tremors.

Journal reference: Current Biology search and more info website

Provided by Oxford University search and more info website

5 /5 (3 votes)  

Rank 5 /5 (3 votes)
Relevant PhysicsForums posts

More news stories

Faulty energy production in brain cells leads to disorders ranging from Parkinson's to intellectual disability

Neuroscientist Patrik Verstreken of VIB (Flanders Institute for Biotechnology) and KU Leuven has shown for the first time that dysfunctional mitochondria in brain cells can lead to learning disabilities. The link between ...

Parkinson's & Movement disorders created May 17, 2013 | popularity 4 / 5 (2) | comments 0

Unleashing the watchdog protein

McGill University researchers have unlocked a new door to developing drugs to slow the progression of Parkinson's disease. Collaborating teams led by Dr. Edward A. Fon at the Montreal Neurological Institute and Hospital -The ...

Parkinson's & Movement disorders created May 09, 2013 | popularity 5 / 5 (1) | comments 0 | with audio podcast

Could eating peppers prevent Parkinson's? Dietary nicotine may hold protective key

New research reveals that Solanaceae—a flowering plant family with some species producing foods that are edible sources of nicotine—may provide a protective effect against Parkinson's disease. The study appearing today ...

Parkinson's & Movement disorders created May 09, 2013 | popularity not rated yet | comments 0

Study reveals probable role of Parkinson's protein in healthy brain

(Medical Xpress)—Researchers at the Stanford University School of Medicine have exposed the possible function, in the healthy brain, of a mysterious molecule that has been strongly implicated in Parkinson's ...

Parkinson's & Movement disorders created May 01, 2013 | popularity 5 / 5 (3) | comments 0 | with audio podcast

Study shows how Parkinson's disease protein acts like a virus

A protein known to be a key player in the development of Parkinson's disease is able to enter and harm cells in the same way that viruses do, according to a Loyola University Chicago Stritch School of Medicine study.

Parkinson's & Movement disorders created Apr 25, 2013 | popularity 5 / 5 (5) | comments 0 | with audio podcast


Researchers identify a potential new risk for sleep apnea: Asthma

Researchers at the University of Wisconsin have identified a potential new risk factor for obstructive sleep apnea: asthma. Using data from the National Institutes of Health (Heart, Lung, and Blood Institute)-funded Wisconsin ...

Study finds that sleep apnea and Alzheimer's are linked

A new study looking at sleep-disordered breathing (SDB) and markers for Alzheimer's disease (AD) risk in cerebrospinal fluid (CSF) and neuroimaging adds to the growing body of research linking the two.

Computational tool translates complex data into simplified 2-dimensional images

In their quest to learn more about the variability of cells between and within tissues, biomedical scientists have devised tools capable of simultaneously measuring dozens of characteristics of individual ...

New theory on genesis of osteoarthritis comes with successful therapy in mice

Scientists at Johns Hopkins have turned their view of osteoarthritis (OA) inside out. Literally. Instead of seeing the painful degenerative disease as a problem primarily of the cartilage that cushions joints, ...

Ginger compounds may be effective in treating asthma symptoms

Gourmands and foodies everywhere have long recognized ginger as a great way to add a little peppery zing to both sweet and savory dishes; now, a study from researchers at Columbia University shows purified components of the ...

'Gap' for HIV vaccine efforts after latest setback

The hunt for an HIV vaccine has gobbled up $8 billion in the past decade, and the failure of the most recent efficacy trial has delivered yet another setback to 26 years of efforts.